VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: A case series with review of the literature

Current Problems in Cancer - Tập 44 - Trang 100568 - 2020
Tugba Akin Telli1, Ilker Nihat Okten2, Tuğba Basoglu Tuylu1, Nazim Can Demircan1, Rukiye Arikan1, Ozkan Alan1, Ozlem Ercelep1, Tunc Ones3, Aysenur Toksoz Yildirim4, Faysal Dane1, Perran Fulden Yumuk1
1Division of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey
2Division of Medical Oncology, Department of Internal Medicine, Medeniyet University School of Medicine, Istanbul, Turkey
3Department of Nucleer Medicine, Marmara University School of Medicine, Istanbul, Turkey
4Department of Pathology, Medeniyet University School of Medicine, Istanbul, Turkey

Tài liệu tham khảo

Yousaf, 2015, Systemic treatment options for epithelioid haemangioendothelioma: The Royal Marsden Hospital experience, Anticancer Res, 35, 473 Makhlouf, 1999, Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases, Cancer, 85, 562, 10.1002/(SICI)1097-0142(19990201)85:3<562::AID-CNCR7>3.0.CO;2-T Lau, 2011, Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer, Chest, 140, 1312, 10.1378/chest.11-0039 Noh, 2019, Treatment and prognosis of hepatic epithelioid hemangioendothelioma based on SEER data analysis from 1973 to 2014, Hepatobiliary Pancreat Dis Int Tong, 2019, The role of local therapy in multi-focal epithelioid haemangioendothelioma, Anticancer Res, 39, 4891, 10.21873/anticanres.13675 Mehrabi, 2006, Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy, Cancer, 107, 2108, 10.1002/cncr.22225 Weiss, 1982, Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma, Cancer, 50, 970, 10.1002/1097-0142(19820901)50:5<970::AID-CNCR2820500527>3.0.CO;2-Z Doyle, 2014, Sarcoma classification: an update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone, Cancer, 120, 1763, 10.1002/cncr.28657 Ishak, 1984, Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases, Hum Pathol, 15, 839, 10.1016/S0046-8177(84)80145-8 Läuffer, 1996, Epithelioid hemangioendothelioma of the liver. A rare hepatic tumor, Cancer, 78, 2318, 10.1002/(SICI)1097-0142(19961201)78:11<2318::AID-CNCR8>3.0.CO;2-I Mehrabi, 2005, Surgical treatment of primary hepatic epithelioid hemangioendothelioma, Transplantation, 80, S109, 10.1097/01.tp.0000186904.15029.4a Pichlmayr, 1994, Indications for liver transplantation in hepatobiliary malignancy, Hepatology, 20, 33S, 10.1002/hep.1840200710 Rodriguez, 2008, Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987 to 2005, J Gastrointest Surg, 12, 110, 10.1007/s11605-007-0247-3 Lerut, 2004, Hepatic haemangioendothelioma in adults: excellent outcome following liver transplantation, Transpl Int, 17, 202, 10.1111/j.1432-2277.2004.tb00429.x Rosenberg, 2018, Epithelioid hemangioendothelioma: update on diagnosis and treatment, Curr Treat Options Oncol, 19, 19, 10.1007/s11864-018-0536-y Morris, 1993, Epithelioid hemangioendothelioma of the liver: A report of two cases, Can J Gastroenterol, 7, 530, 10.1155/1993/523796 Idilman, 1997, Successful medical treatment of an epithelioid hemangioendothelioma of liver, Oncology, 54, 171, 10.1159/000227683 Gambacorta, 1989, Epithelioid hemangioendothelioma: report of a case diagnosed by fine-needle aspiration, Diagn Cytopathol, 5, 207, 10.1002/dc.2840050218 Kelly, 2005, Response of epithelioid haemangioendothelioma to liposomal doxorubicin, Lancet Oncol, 6, 813, 10.1016/S1470-2045(05)70392-2 Grenader, 2011, Malignant epithelioid hemangioendothelioma of the liver successfully treated with pegylated liposomal doxorubicin, J Clin Oncol, 29, e722, 10.1200/JCO.2011.35.5891 Pinet, 1999, Aggressive form of pleural epithelioid haemangioendothelioma: complete response after chemotherapy, Eur Respir J, 14, 237, 10.1034/j.1399-3003.1999.14a40.x Stacher, 2009, The VEGF-system in primary pulmonary angiosarcomas and haemangioendotheliomas: new potential therapeutic targets?, Lung Cancer, 65, 49, 10.1016/j.lungcan.2008.10.031 Belmont, 2008, Pulmonary epithelioid haemangioendothelioma and bevacizumab, J Thorac Oncol, 3, 557, 10.1097/JTO.0b013e31816e2400 Kim, 2010, Treatment of pulmonary epithelioid hemangioendothelioma with bevacizumab, J Thorac Oncol, 5, 1107, 10.1097/JTO.0b013e3181e2bc5d Mizota, 2011, Bevacizumab chemotherapy for pulmonary epithelioid hemangioendothelioma with severe dyspnea, J Thorac Oncol, 6, 651, 10.1097/JTO.0b013e31820b9e23 Kanemura, 2016, Pemetrexed for epithelioid haemangioendothelioma of the pleura, Respirol Case Rep, 4, e00191, 10.1002/rcr2.191 Trautmann, 2011, Bevacizumab for recurrent hemangioendothelioma, Acta Oncol, 50, 153, 10.3109/0284186X.2010.498829 Merikas, 2015, Epithelioid hemangioendothelioma treated with bevacizumab: a case series, Cancer Treatment Communications, 4, 59, 10.1016/j.ctrc.2015.05.005 Lazarus, 2011, Primary pleural epithelioid hemangioendothelioma (EHE)–two cases and review of the literature, Clin Respir J, 5, e1, 10.1111/j.1752-699X.2010.00221.x Gaur, 2012, Activity of angiogenesis inhibitors in metastatic epithelioid hemangioendothelioma: a case report, Cancer Biol Med, 9, 133 Agulnik, 2013, An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas, Ann Oncol, 24, 257, 10.1093/annonc/mds237 Lau, 2015, Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma, Ther Adv Med Oncol, 7, 229, 10.1177/1758834015582206 Chevreau, 2013, Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO), Cancer, 119, 2639, 10.1002/cncr.28109 Bally, 2015, Eight years tumor control with pazopanib for a metastatic resistant epithelioid hemangioendothelioma, Clin Sarcoma Res, 5, 12, 10.1186/s13569-014-0018-3 Zheng, 2017, Apatinib for the treatment of pulmonary epithelioid hemangioendothelioma: A case report and literature review, Medicine (Baltimore), 96, e8507, 10.1097/MD.0000000000008507 Tolkach, 2012, Epithelioid hemangioendothelioma of the kidney treated with sunitinib, Onkologie, 35, 376, 10.1159/000338944 Salech, 2011, Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with a long term follow-up, Ann Hepatol, 10, 99, 10.1016/S1665-2681(19)31596-0 Mascarenhas, 2004, Thalidomide inhibits the growth and progression of hepatic epithelioid hemangioendothelioma, Oncology, 67, 471, 10.1159/000082932 Sumrall, 2010, Lenalidomide stops progression of multifocal epithelioid hemangioendothelioma including intracranial disease, J Neurooncol, 97, 275, 10.1007/s11060-009-0017-z Otrock, 2006, Spontaneous complete regression of hepatic epithelioid haemangioendothelioma, Lancet Oncol, 7, 439, 10.1016/S1470-2045(06)70697-0